| RS1330554738 |
CYP21A2
|
Health Risk |
Pathogenic |
Congenital adrenal hyperplasia, Congenital adrenal hyperplasia |
| RS1330564240 |
GALNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-IV-A |
| RS1330578621 |
SLC25A20
|
Health Risk |
Pathogenic/Likely pathogenic |
Carnitine acylcarnitine translocase deficiency, Carnitine acylcarnitine translocase deficiency |
| RS1330593620 |
MSH3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 4 |
| RS1330596542 |
GJC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypomyelinating leukodystrophy 2, Spastic paraplegia |
| RS13306026 |
PTGIS
|
Health Risk |
Pathogenic |
Essential hypertension, Essential hypertension |
| RS13306068 |
ABCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypoalphalipoproteinemia, primary |
| RS13306073 |
ABCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tangier disease, Hypoalphalipoproteinemia |
| RS13306077 |
ABCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypoalphalipoproteinemia, primary |
| RS13306080 |
ABCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypoalphalipoproteinemia, primary |
| RS13306091 |
ACE
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal tubular dysgenesis, Renal tubular dysgenesis of genetic origin |
| RS1330612935 |
ARMC9
|
Health Risk |
Pathogenic |
Joubert syndrome 30, Joubert syndrome 30 |
| RS1330614261 |
RECQL4
|
Health Risk |
Pathogenic |
Baller-Gerold syndrome, Baller-Gerold syndrome |
| RS13306155 |
AGT
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal tubular dysgenesis, Essential hypertension |
| RS13306187 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypobetalipoproteinemia 1, Hypercholesterolemia |
| RS13306188 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS13306191 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS13306193 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS13306194 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypobetalipoproteinemia 1, Hypercholesterolemia |
| RS13306196 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS13306206 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS1330621664 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1330624821 |
PEX13
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 11A (Zellweger), Peroxisome biogenesis disorder 11A (Zellweger) |
| RS1330628156 |
EPHB4
|
Health Risk |
Conflicting classifications of pathogenicity |
Capillary malformation-arteriovenous malformation 2, EPHB4-related disorder |
| RS13306300 |
CYBB
|
Health Risk |
Conflicting classifications of pathogenicity |
Granulomatous disease, chronic |
| RS1330631412 |
MYO15A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS13306372 |
FN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Glomerulopathy with fibronectin deposits 2, Spondylometaphyseal dysplasia - Sutcliffe type |
| RS13306415 |
GYS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease due to muscle and heart glycogen synthase deficiency, Glycogen storage disease due to muscle and heart glycogen synthase deficiency |
| RS13306444 |
INS;INS-IGF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young type 10, Transient Neonatal Diabetes |
| RS13306449 |
INSR
|
Health Risk |
Conflicting classifications of pathogenicity |
Leprechaunism syndrome, Insulin-resistant diabetes mellitus AND acanthosis nigricans |
| RS13306476 |
ITGB3
|
Health Risk |
Likely pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS13306505 |
LDLR
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS13306510 |
LDLR
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS13306512 |
LDLR
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS13306515 |
LDLR
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypercholesterolemia, familial |
| RS13306528 |
LEPR
|
Health Risk |
Conflicting classifications of pathogenicity |
Obesity due to leptin receptor gene deficiency, Obesity due to leptin receptor gene deficiency |
| RS1330659380 |
RBM20
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1DD, Cardiovascular phenotype |
| RS13306627 |
SCNN1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Pseudohypoaldosteronism, type IB1 |
| RS13306633 |
SCNN1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Liddle syndrome 1, Pseudohypoaldosteronism |
| RS13306666 |
SLC12A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypokalemia-hypomagnesemia, Familial hypokalemia-hypomagnesemia |
| RS13306668 |
SLC12A3
|
Health Risk |
Pathogenic |
Familial hypokalemia-hypomagnesemia, Familial hypokalemia-hypomagnesemia |
| RS1330667099 |
XPC
|
Health Risk |
Pathogenic |
Xeroderma pigmentosum, group C |
| RS1330675110 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS13306758 |
SLC2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Epilepsy, idiopathic generalized |
| RS1330676517 |
NF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Neurofibromatosis |
| RS13306774 |
SLC4A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spherocytosis type 4, Hereditary spherocytosis type 4 |
| RS13306776 |
SLC4A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spherocytosis type 4, Autosomal dominant distal renal tubular acidosis |
| RS13306787 |
SLC4A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal dominant distal renal tubular acidosis, Hereditary spherocytosis type 4 |
| RS1330705989 |
F9
|
Health Risk |
Likely pathogenic |
F9-related disorder, F9-related disorder |
| RS1330723939 |
IL17RA
|
Health Risk |
Pathogenic |
Immunodeficiency 51, Immunodeficiency 51 |
| RS1330743871 |
LRPPRC
|
Health Risk |
Likely pathogenic |
Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type |
| RS1330745435 |
CEP290
|
Health Risk |
Conflicting classifications of pathogenicity |
Meckel-Gruber syndrome, Nephronophthisis |
| RS1330765503 |
SPAG1
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia 28, Primary ciliary dyskinesia 28 |
| RS1330765515 |
MTPAP
|
Health Risk |
Likely pathogenic |
Spastic ataxia, Spastic ataxia |
| RS1330779100 |
P3H1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta |
| RS1330779541 |
F9
|
Health Risk |
Pathogenic |
Hereditary factor IX deficiency disease, Thrombophilia |
| RS1330791390 |
MSH3
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 4, Familial adenomatous polyposis 4 |
| RS1330792627 |
WT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Drash syndrome, Frasier syndrome |
| RS1330793674 |
BCKDHA
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS1330811896 |
FUCA1
|
Health Risk |
Pathogenic |
Fucosidosis, Fucosidosis |
| RS1330826129 |
EHMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Kleefstra syndrome 1, Inborn genetic diseases |
| RS1330827109 |
AKAP9
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS1330853690 |
SMARCAL1
|
Health Risk |
Pathogenic |
Schimke immuno-osseous dysplasia, Schimke immuno-osseous dysplasia |
| RS1330865474 |
TP53
|
Health Risk |
Pathogenic |
Li-Fraumeni syndrome, Lung sarcomatoid carcinoma |
| RS1330873923 |
MED12
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, FG syndrome |
| RS1330875156 |
TPP1
|
Health Risk |
Likely pathogenic |
Cervical cancer, Neuronal ceroid lipofuscinosis 2 |
| RS1330890210 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS1330899688 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS1330900330 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, CHARGE syndrome |
| RS1330915067 |
LAMB2
|
Health Risk |
Likely pathogenic |
LAMB2-related infantile-onset nephrotic syndrome, Pierson syndrome |
| RS1330915229 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Tuberous sclerosis syndrome |
| RS1330919125 |
SETX
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 4, Spinocerebellar ataxia |
| RS1330933906 |
COL6A1
|
Health Risk |
Pathogenic/Likely pathogenic |
COL6A1-related disorder, Bethlem myopathy 1A |
| RS1330937621 |
RAD51C
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group O, Hereditary cancer-predisposing syndrome |
| RS1330937800 |
NACC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1330942177 |
TRPS1
|
Health Risk |
Pathogenic |
Trichorhinophalangeal syndrome, type III |
| RS1330944743 |
HFE
|
Health Risk |
Pathogenic |
Hereditary hemochromatosis, Hereditary hemochromatosis |
| RS1330960948 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Hypertrophic cardiomyopathy 9 |
| RS1330961789 |
COL27A1
|
Health Risk |
Pathogenic |
— |
| RS1330990917 |
MED12
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked intellectual disability with marfanoid habitus, FG syndrome |
| RS1330992740 |
CWF19L1
|
Health Risk |
Likely pathogenic |
Autosomal recessive spinocerebellar ataxia 17, Autosomal recessive spinocerebellar ataxia 17 |
| RS1330994397 |
GOSR2
|
Health Risk |
Pathogenic |
Progressive myoclonic epilepsy, Progressive myoclonic epilepsy |
| RS1331019600 |
HPS5
|
Health Risk |
Pathogenic |
— |
| RS1331026006 |
CHD8
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with autism and macrocephaly, Intellectual developmental disorder with autism and macrocephaly |
| RS1331043174 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1331062755 |
NEB
|
Health Risk |
Likely pathogenic |
Arthrogryposis multiplex congenita 6, Nemaline myopathy 2 |
| RS1331064724 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS1331075407 |
NAXD
|
Health Risk |
Likely pathogenic |
NAD(P)HX dehydratase deficiency, NAD(P)HX dehydratase deficiency |
| RS1331100491 |
ASPA
|
Health Risk |
Pathogenic/Likely pathogenic |
Spongy degeneration of central nervous system, Canavan Disease |
| RS1331106064 |
GRHPR
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary hyperoxaluria, type II |
| RS1331110870 |
CDK13
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1331111339 |
FMO3
|
Health Risk |
Pathogenic |
Trimethylaminuria, Trimethylaminuria |
| RS1331134740 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group O |
| RS1331155296 |
PHGDH
|
Health Risk |
Pathogenic |
PHGDH deficiency, Neu-Laxova syndrome 1 |
| RS1331157104 |
GYS1
|
Health Risk |
Pathogenic |
Glycogen storage disease due to muscle and heart glycogen synthase deficiency, Glycogen storage disease due to muscle and heart glycogen synthase deficiency |
| RS1331207836 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1331215787 |
TCTN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Meckel-Gruber syndrome, Joubert syndrome |
| RS1331217337 |
SETX
|
Health Risk |
Pathogenic/Likely pathogenic |
Amyotrophic lateral sclerosis type 4, Spinocerebellar ataxia |
| RS1331241591 |
EVC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Curry-Hall syndrome, Ellis-van Creveld syndrome |
| RS1331260332 |
COL6A2
|
Health Risk |
Pathogenic/Likely pathogenic |
COL6A2-related disorder, COL6A2-related disorder |